- Injection advertisements
- $199 / $299 monthly advertised rates, semaglutide / tirzepatide; actual debit unconfirmed
- Longer-plan advertisements
- $179 / $269 per advertised month for 24 weeks; $159 / $239 for 48 weeks. Labels do not establish calendar-month supply
- Branded care fee
- $99/$125 monthly advertisements conflict; medication separate
- Required quote
- Confirm initial and recurring charges, billing interval, minimum term, prescribed dose, monthly-plan supply and state eligibility
- Cancellation and refunds
- Billing and shipment cutoffs differ; ordinary refunds can reprice used months, with separate medical and provider-initiated protections. Participation-dependent promise does not cancel a longer plan